A volunteer participating in the AstraZeneca vaccine trial having blood drawn in Oxford, England, Nov. 19, 2020. AstraZeneca’s new clinical trial results are positive but confusing, leaving many experts wanting to see more data before passing final judgment on how well the coronavirus vaccine will work. (Andrew Testa/The New York Times)
While Connecticut officials urge more federal funding for COVID-19 vaccine distribution, Gov. Lamont says he’s prepared to dip into the state’s rainy day fund
